Pharmaceuticals news FT.com

Novo Nordisk ousts boss as Ozempic maker battles slump

Danish maker of obesity drugs to replace Lars Fruergaard Jørgensen, saying new leadership is needed

May 16, 2025 - 13:46
 0
Novo Nordisk ousts boss as Ozempic maker battles slump
Danish maker of obesity drugs to replace Lars Fruergaard Jørgensen, saying new leadership is needed
Read More

Tags:

Previous Article

Chutes & Ladders—BMS oncology head swings to Syndax

Next Article

Human medicines European public assessment report (EPAR): Matever, levetiracetam...

Related Posts

White House pushes lower US drugs prices with tariff threat to Europe

White House pushes lower US drugs prices with tariff th...

May 12, 2025  0

GSK turns to AI to offset potential US tariff hit

GSK turns to AI to offset potential US tariff hit

May 12, 2025  0

Novo Nordisk partners with US biotech to boost pipeline of new obesity drugs

Novo Nordisk partners with US biotech to boost pipeline...

May 14, 2025  0